US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

SANUWAVE Health, Inc.

29.13

+2.087.69%

Post-market: 29.130.00000.00%16:00 EDT

Volume:59.21K

Turnover:1.69M

Market Cap:249.02M

PE:-4.14

High:29.50

Open:27.05

Low:27.05

Close:27.05

Loading ...

Overview Company News Filings

Sanuwave Health Announces Preliminary Revenue Results For The First Quarter 2025

Sanuwave Health : Does Not Anticipate Any Significant Effects on Production From Current Tariff Situation

THOMSON REUTERS

Sanuwave Health Announces Preliminary Revenue Results for the First Quarter 2025 (Ended March 31, 2025)

THOMSON REUTERS

Press Release: SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2025 (Ended March 31, 2025)

Sanuwave Health Shares Rise on 2025 Outlook

SANUWAVE Health Q4 Sales $10.326M Up From $6.994M YoY

Sanuwave Health Inc: Outlook 2025 Revenue Guidance of $48 Mln - 50 Mln

THOMSON REUTERS

Sanuwave Announces Record Quarterly Revenues: Q4 FY2024 Financial Results

THOMSON REUTERS

Sanuwave Health Inc: Outlook Q1 2025 Revenue of $8.4 Mln to $9.0 Mln

THOMSON REUTERS

Sanuwave Health Inc: Q4 Revenue $10.3 Mln

THOMSON REUTERS

Press Release: SANUWAVE Announces Record Quarterly Revenues: Q4 FY2024 Financial Results

Why We're Not Concerned About SANUWAVE Health, Inc.'s (NASDAQ:SNWV) Share Price

Simply Wall St.

BRIEF-Sanuwave Health To Uplist To The Nasdaq Global Market

Sanuwave Health to Uplist to the Nasdaq Global Market

THOMSON REUTERS

Press Release: SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results

SANUWAVE Health Q3 EPS $(6.49) Up From $(9.95) YoY, Sales $9.36M Up From $4.95M YoY

Press Release: SANUWAVE Will Host a Conference Call on November 8, 2024 at 8:30 AM (ET) to Present Q3 Financial Results

Sanuwave Health Inc - 1-for-375 Reverse Stock Split Effective at Market Open Today

THOMSON REUTERS

Sanuwave Health Announces 1-for-375 Reverse Stock Split

THOMSON REUTERS

Sanuwave Health Inc - Common Stock to Begin Trading on Split-Adjusted Basis Oct 18, 2024

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/SNWV/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"SNWV","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNWV\",,,,,undefined,":{"symbol":"SNWV","market":"US","secType":"STK","nameCN":"SANUWAVE Health, Inc.","latestPrice":29.13,"timestamp":1746129600000,"preClose":27.05,"halted":0,"volume":59212,"hourTrading":{"tag":"盘后","latestPrice":29.13,"preClose":29.13,"latestTime":"16:00 EDT","volume":202,"amount":5884.26,"timestamp":1746129620494},"delay":0,"floatShares":4608154,"shares":8548473,"eps":-7.029536,"marketStatus":"Post-Mkt","change":2.08,"latestTime":"05-01 16:02:51 EDT","open":27.05,"high":29.5,"low":27.05,"amount":1694236.3198,"amplitude":0.090573,"askPrice":0,"askSize":0,"bidPrice":11.3,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-7.029536,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1746144000000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":27.05,"postHourTrading":{"tag":"盘后","latestPrice":29.13,"preClose":29.13,"latestTime":"16:00 EDT","volume":202,"amount":5884.26,"timestamp":1746129620494},"volumeRatio":0.950046},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"SNWV\",,,,,undefined,":{"symbol":"SNWV","floatShares":4608154,"roa":"12.89%","roe":"196.48%","lyrEps":-7.029536,"volumeRatio":0.950046,"shares":8548473,"dividePrice":0,"high":29.5,"amplitude":0.090573,"preClose":27.05,"low":27.05,"week52Low":5.1743,"pbRate":"-19.58","psRate":"7.63","week52High":39.5,"institutionHeld":0,"latestPrice":29.13,"committee":1,"eps":-7.029536,"divideRate":0,"volume":59212,"delay":0,"ttmEps":-7.029536,"open":27.05,"prevYearClose":23,"prevWeekClose":28.48,"prevMonthClose":27.05,"prevQuarterClose":35.37,"fiveDayClose":29.75,"twentyDayClose":33.75,"sixtyDayClose":27.62,"earningDate":1746720000000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"SNWV\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2525481846","title":"Sanuwave Health Announces Preliminary Revenue Results For The First Quarter 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2525481846","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525481846?lang=en_us&edition=fundamental","pubTime":"2025-04-08 21:45","pubTimestamp":1744119934,"startTime":"0","endTime":"0","summary":"April 8 (Reuters) - SANUWAVE Health Inc ::*SANUWAVE HEALTH ANNOUNCES PRELIMINARY REVENUE RESULTS FOR THE FIRST QUARTER 2025 (ENDED MARCH 31, 2025)*SANUWAVE HEALTH : DOES NOT ANTICIPATE ANY SIGNIFICANT","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nRSD4SpDml:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWVD","SNWV"],"gpt_icon":0},{"id":"2525891756","title":"Sanuwave Health : Does Not Anticipate Any Significant Effects on Production From Current Tariff Situation","url":"https://stock-news.laohu8.com/highlight/detail?id=2525891756","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525891756?lang=en_us&edition=fundamental","pubTime":"2025-04-08 20:30","pubTimestamp":1744115402,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nTUA6NHNHL:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNWV","BK4082"],"gpt_icon":0},{"id":"2525891206","title":"Sanuwave Health Announces Preliminary Revenue Results for the First Quarter 2025 (Ended March 31, 2025)","url":"https://stock-news.laohu8.com/highlight/detail?id=2525891206","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525891206?lang=en_us&edition=fundamental","pubTime":"2025-04-08 20:30","pubTimestamp":1744115402,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250408:nTUA6NHNHL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","SNWV"],"gpt_icon":0},{"id":"2525891216","title":"Press Release: SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2025 (Ended March 31, 2025)","url":"https://stock-news.laohu8.com/highlight/detail?id=2525891216","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2525891216?lang=en_us&edition=fundamental","pubTime":"2025-04-08 20:30","pubTimestamp":1744115400,"startTime":"0","endTime":"0","summary":"SANUWAVE is pleased to announce preliminary revenues of $9.1 million to $9.3 million for the first quarter ended March 31, 2025. This represents the highest Q1 quarterly revenues in Company history.Q1 2025 revenue increased between 57% and 61% compared to Q1 2024.UltraMIST revenues for Q1 2025 increased by more than 65% versus Q1 2024 and accounted for approximately 99% of the Company's total revenues.\"Sanuwave is pleased to announce a strong start to 2025, putting up our best Q1 in Company history,\" said CEO Morgan Frank. \"Q1 was a transition quarter as we moved to a new head of sales and restructured the sales force. I'm very proud of the team managing this without missing a beat. Our pipeline remains robust and consistent with 2025 being a breakout year for Sanuwave. The Company plans to release its full Q1 results on or around May 9, 2025 and we look forward to speaking with you then to give you a more complete update on our quarterly performance and our future plans and guidance.\"","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWV"],"gpt_icon":0},{"id":"2521557202","title":"Sanuwave Health Shares Rise on 2025 Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2521557202","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521557202?lang=en_us&edition=fundamental","pubTime":"2025-03-22 03:05","pubTimestamp":1742583900,"startTime":"0","endTime":"0","summary":"Shares of Sanuwave Health climbed on the path toward their highest close in almost three years after the company guided for further growth in 2025.The stock gained 13%, to $36.20, in Friday afternoon trading. Shares are up 57% year to date.The developer of patented noninvasive, biological response activating devices said it expects revenue of $48 million to $50 million for 2025 as it guided for a first-quarter top-line performance between $8.4 million and $9 million.In 2024, the company had reported revenue of $32.6 million.\"We are confident that our revenue pipeline is stronger than it has ever been and have been ramping up our sales force and sales strategy to meet this opportunity and to effectively manage the larger customers with whom we continue to engage,\" Chief Executive Morgan Frank said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWV","BK4082"],"gpt_icon":0},{"id":"2521640309","title":"SANUWAVE Health Q4 Sales $10.326M Up From $6.994M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2521640309","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521640309?lang=en_us&edition=fundamental","pubTime":"2025-03-21 18:05","pubTimestamp":1742551536,"startTime":"0","endTime":"0","summary":"SANUWAVE Health Q4 Sales $10.326M Up From $6.994M YoY","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/03/44432262/sanuwave-health-q4-sales-10-326m-up-from-6-994m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWV"],"gpt_icon":0},{"id":"2521840349","title":"Sanuwave Health Inc: Outlook 2025 Revenue Guidance of $48 Mln - 50 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2521840349","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521840349?lang=en_us&edition=fundamental","pubTime":"2025-03-21 18:00","pubTimestamp":1742551201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nTUA2HHMQR:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNWV","BK4082"],"gpt_icon":0},{"id":"2521408080","title":"Sanuwave Announces Record Quarterly Revenues: Q4 FY2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2521408080","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521408080?lang=en_us&edition=fundamental","pubTime":"2025-03-21 18:00","pubTimestamp":1742551201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nTUA2HHMQR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","SNWV"],"gpt_icon":0},{"id":"2521403932","title":"Sanuwave Health Inc: Outlook Q1 2025 Revenue of $8.4 Mln to $9.0 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2521403932","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521403932?lang=en_us&edition=fundamental","pubTime":"2025-03-21 18:00","pubTimestamp":1742551201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nTUA2HHMQR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","SNWV"],"gpt_icon":0},{"id":"2521403238","title":"Sanuwave Health Inc: Q4 Revenue $10.3 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2521403238","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521403238?lang=en_us&edition=fundamental","pubTime":"2025-03-21 18:00","pubTimestamp":1742551201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250321:nTUA2HHMQR:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNWV","BK4082"],"gpt_icon":0},{"id":"2521403056","title":"Press Release: SANUWAVE Announces Record Quarterly Revenues: Q4 FY2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2521403056","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521403056?lang=en_us&edition=fundamental","pubTime":"2025-03-21 18:00","pubTimestamp":1742551200,"startTime":"0","endTime":"0","summary":"Q4 2024 revenues were $10.3 million, up 47% from Q4 2023. This was an all-time quarterly record for the Company.Full year 2024 revenues were $32.6 million, up 60% from full year 2023 revenues. This was an all-time annual record for the Company.Q4 2024 gross margin was 77.9%, versus 69.1% in Q4 2023 and 75.5% in Q3 2024.Full year 2024 gross margin was 75.2% versus 70.4% in 2023.GAAP Operating Income was $2.5 million for Q4 2024 and $5.4 million for full year 2024.Company provides guidance for revenue growth of 45-55% for Q1 2025 as compared to Q1 2024 and initiates full year 2025 revenue guidance of $48-50 million for full year 2025 . -- Revenue for the three months ended December 31, 2024, totaled $10.3. million, an increase of 47%, as compared to $7.0 million for the same. revenue represented 58% of overall revenues in Q4 2024. UltraMIST systems. Company and represented over 99% of SANUWAVE's overall revenues in Q4. $3.7 million versus Adjusted EBITDA of $0.7 million for the same peri","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWV"],"gpt_icon":0},{"id":"2517843063","title":"Why We're Not Concerned About SANUWAVE Health, Inc.'s (NASDAQ:SNWV) Share Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2517843063","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517843063?lang=en_us&edition=fundamental","pubTime":"2025-03-07 21:09","pubTimestamp":1741352949,"startTime":"0","endTime":"0","summary":"You may think that with a price-to-sales (or \"P/S\") ratio of 9.2x SANUWAVE Health, Inc. ( NASDAQ:SNWV ) is a stock to...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6021000-choice1-main-header/1585186659638"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-snwv/sanuwave-health/news/why-were-not-concerned-about-sanuwave-health-incs-nasdaqsnwv","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["SNWVD","SNWV","MNQmain","PSQ","LU2210149790.SGD","IE00BKPKM429.USD","SQQQ","NVIW.SI","IE00B64PRP62.GBP","NDAQ","BK4112","USJW.SI","LU2095319765.USD","IE00B3QW5Z07.USD","USAW.SI","NQmain","BK4585","BK4082","LU2210150020.SGD","TQQQ","QLD","IE00BGHQF748.EUR","TSYW.SI",".IXIC","QID","BK4588"],"gpt_icon":1},{"id":"2517498430","title":"BRIEF-Sanuwave Health To Uplist To The Nasdaq Global Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2517498430","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517498430?lang=en_us&edition=fundamental","pubTime":"2025-03-05 05:52","pubTimestamp":1741125139,"startTime":"0","endTime":"0","summary":"BRIEF-Sanuwave Health To Uplist To The Nasdaq Global MarketMarch 4 (Reuters) - SANUWAVE Health Inc SNWV.PK:SANUWAVE HEALTH TO UPLIST TO THE NASDAQ GLOBAL MARKETSource text: ID:nGNX6qz5jlFurther company coverage: SNWV.PK ((Reuters.Briefs@thomsonreuters.com;))","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nFWN3PN0JC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWV","BK4082"],"gpt_icon":0},{"id":"2517981660","title":"Sanuwave Health to Uplist to the Nasdaq Global Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2517981660","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2517981660?lang=en_us&edition=fundamental","pubTime":"2025-03-05 05:35","pubTimestamp":1741124117,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250304:nFWN3PN0JC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNWV","BK4082"],"gpt_icon":0},{"id":"2481178865","title":"Press Release: SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2481178865","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481178865?lang=en_us&edition=fundamental","pubTime":"2024-11-08 19:24","pubTimestamp":1731065040,"startTime":"0","endTime":"0","summary":"Q3 2024 revenues were $9.4 million, up 89% from Q3 2023. This was an all-time quarterly record for the Company.Q3 2024 gross margin was 75.5%, vs 71.5% in Q3 2023. Company provides guidance for revenue growth of 40-50% for Q4 2024 versus Q4 2023. -- Revenue for the three months ended September 30, 2024, totaled $9.4. million, an increase of 89%, as compared to $5.0 million for the same. period of 2023. This growth is greater than the previously provided. -- 124 UltraMist systems were sold in Q3 2024 up from 55 in Q3 2023 and. UltraMIST systems and consumables remained the primary revenue growth. months ended September 30, 2024, versus 71.5% for the same period last. \"The third quarter showed acceleration in revenue growth rate from the first half of the year with growth of 89% year on year  leading the company to a growth rate of 68% for the first nine months of 2024 as compared to the same period in 2023,\" said Morgan Frank, CEO. \"Obviously, we're very pleased with these results, espe","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","BK4232","R","SNWV","BK4082"],"gpt_icon":0},{"id":"2481166883","title":"SANUWAVE Health Q3 EPS $(6.49) Up From $(9.95) YoY, Sales $9.36M Up From $4.95M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2481166883","media":"Benzinga","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2481166883?lang=en_us&edition=fundamental","pubTime":"2024-11-08 07:52","pubTimestamp":1731023542,"startTime":"0","endTime":"0","summary":"SANUWAVE Health (OTC:SNWV) reported quarterly losses of $(6.49) per share. This is a 42.31 percent increase over losses of $(11.25) per share from the same period last year.  The company reported $9.36 million in sales","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/24/11/41830842/sanuwave-health-q3-eps-6-49-up-from-9-95-yoy-sales-9-36m-up-from-4-95m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"SANUWAVE Health Q3 EPS $(6.49) Up From $(9.95) YoY, Sales $9.36M Up From $4.95M YoY","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWV"],"gpt_icon":0},{"id":"2480302938","title":"Press Release: SANUWAVE Will Host a Conference Call on November 8, 2024 at 8:30 AM (ET) to Present Q3 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2480302938","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2480302938?lang=en_us&edition=fundamental","pubTime":"2024-11-04 20:34","pubTimestamp":1730723640,"startTime":"0","endTime":"0","summary":"EDEN PRAIRIE, Minn., Nov. 04, 2024  -- SANUWAVE Health, Inc.  , a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, November 8, 2024, at 8:30 AM  to present its Q3 2024 financial results.Telephone access to the call will be available by dialing the following numbers:. OR click the link for instant telephone access to the event:. SANUWAVE Health is focused on the research, development, and commercialization of its patented, non-invasive and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SNWV","BK4581","BK4144","BK4218","BK4585","BK4082","BK4588","ET","BK4590","BK4181","BK4561","AM","HST"],"gpt_icon":0},{"id":"2476302234","title":"Sanuwave Health Inc - 1-for-375 Reverse Stock Split Effective at Market Open Today","url":"https://stock-news.laohu8.com/highlight/detail?id=2476302234","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2476302234?lang=en_us&edition=fundamental","pubTime":"2024-10-18 21:00","pubTimestamp":1729256401,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241018:nTUA3MV8ZK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNWV","BK4082"],"gpt_icon":0},{"id":"2475615359","title":"Sanuwave Health Announces 1-for-375 Reverse Stock Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2475615359","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475615359?lang=en_us&edition=fundamental","pubTime":"2024-10-16 19:30","pubTimestamp":1729078200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241016:nTUA5KGCWC:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNWV","BK4082"],"gpt_icon":0},{"id":"2475396169","title":"Sanuwave Health Inc - Common Stock to Begin Trading on Split-Adjusted Basis Oct 18, 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2475396169","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2475396169?lang=en_us&edition=fundamental","pubTime":"2024-10-16 19:30","pubTimestamp":1729078200,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241016:nTUA5KGCWC:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SNWV","BK4082"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":20,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/SNWV\",params:#limit:5,,,undefined,":[{"date":"2025-04-08","symbol":"SNWV","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1744099200000,"name":null,"time":"Pre-Market","dateTimestamp":1744084800000,"actualEps":null},{"date":"2025-03-21","symbol":"SNWV","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/12","expectedEps":null,"defaultRemindTime":1742544000000,"name":null,"time":"Pre-Market","dateTimestamp":1742529600000,"actualEps":null},{"market":"US","date":"2024-11-08","symbol":"SNWV","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1731042000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2024-10-18","symbol":"SNWV","defaultRemindTime":1729258200000,"type":"split","dateTimestamp":1729224000000,"forFactor":7874,"toFactor":21,"ratio":374.95238095238096},{"date":"2024-08-13","symbol":"SNWV","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1723536000000,"name":null,"time":"Pre-Market","dateTimestamp":1723521600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"SNWV\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"SNWV\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/SNWV\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"SNWV","date":"2025-04-30","current":-7.021999,"percent":1,"low":-702.038129,"twenty":-618.407835,"median":-9.417162,"eighty":-7.982244,"high":-7.021999,"avg":-195.38841,"sd":293.321138,"marketCap":220294149},"quantilePoints":[{"date":"2025-03-07","current":-691.068781,"twenty":-691.068781,"median":-691.068781,"eighty":-691.068781,"marketCap":268825756},{"date":"2025-03-14","current":-618.012938,"twenty":-636.222054,"median":-618.342019,"eighty":-603.314015,"marketCap":240407033},{"date":"2025-03-21","current":-702.038129,"twenty":-696.553455,"median":-636.222054,"eighty":-618.012938,"marketCap":273092832},{"date":"2025-03-28","current":-10.158328,"twenty":-695.675907,"median":-618.342019,"eighty":-10.354519,"marketCap":318687073},{"date":"2025-04-04","current":-8.120123,"twenty":-691.068781,"median":-601.668614,"eighty":-10.158328,"marketCap":254744495},{"date":"2025-04-11","current":-7.981154,"twenty":-636.222054,"median":-10.315009,"eighty":-8.485256,"marketCap":250384774},{"date":"2025-04-17","current":-7.964805,"twenty":-631.834315,"median":-10.235987,"eighty":-8.284706,"marketCap":249871865},{"date":"2025-04-25","current":-8.106499,"twenty":-621.084356,"median":-9.959412,"eighty":-8.117398,"marketCap":254317071},{"date":"2025-04-30","current":-7.021999,"twenty":-618.407835,"median":-9.417162,"eighty":-7.982244,"marketCap":220294149}],"updateTime":1746129771418}}}